Andhra Petrochemicals restarts plant operations from August 5

The announcement was formally communicated to The Bombay Stock Exchange Ltd. on August 4, 2026. G. Adinarayana, CFO & Company Secretary of The Andhra Petrochemicals Limited, signed the intimation letter, which cites Regulation 30 of the SEBI (Listing Obligations and Disclosure standards) Regulations, 2015. The filing references a previous correspondence dated March 17, 2026, indicating that this restart follows a prolonged planning or maintenance phase.

The key dates adjacent the operational restart are detailed below:

The company ensured prompt disclosure by submitting the intimation to the exchange on the day preceding the actual restart. Adherence to Regulation 30 of the SEBI LODR Regulations mandates such continuous disclosure obligations to listed entities to ensure market transparency. The specific reference to the March 17, 2026 letter suggests that investors were previously aware of the planned downtime or maintenance schedule, with this current filing serving as the final confirmation of the resumption date.

The restart of plant operations is a material research to shareholders, as it signals the possible return of revenue generation from the affected facility. to a manufacturing entity like The Andhra Petrochemicals Limited, operational continuity is immediately linked to cash flow stability and order fulfillment capacity. The precise dating of the restart allows downstream customers and suppliers to adjust their logistics and inventory planning accordingly. While the filing does not specify the expected output volume or the duration of the preceding shutdown, the definitive environment of the "w.e.f. 5th August, 2026" statement provides clarity on the immediate operational status.

Investors should monitor subsequent quarterly results to assess the impact of this restart on revenue figures and operating margins. The gap between the March disclosure and the August restart implies a substantial period of non-operation, making the efficiency of the ramp-up phase a critical factor in near-term financial performance.

Andhra Petrochemicals has confirmed the cessation of Dr. Pamidi Kotaiah from its Board of Directors following his death on the night of July 23, 2026. The company informed the Bombay Stock Exchange that Dr. Kotaiah’s roles as Chairman and Director ended efficiently July 24, 2026, marking a significant leadership transition to the West Godavari-based chemical manufacturer.

The intimation was issued under Clause 30 of the SEBI (LODR) Regulations, 2015, which mandates disclosure of changes in the composition of the Board. Dr. Pamidi Kotaiah, identified by DIN 00038420, served as a Non-Executive and Independent Director. His departure leaves a vacancy in the company's top leadership structure, requiring future board action to appoint a successor in compliance with regulatory norms to independent director representation.

The company provided specific details regarding the timeline and regulatory basis to the exit in its filing to the exchange.

The notice was signed by G. Adinarayana, who holds the dual role of Chief Financial Officer and Company Secretary at Andhra Petrochemicals. The filing was digitally signed and submitted on July 24, 2026, at 11:44:11 AM.

As an Independent Director, Dr. Kotaiah played a critical role in the company’s governance framework, providing oversight independent of regulation. His sudden passing necessitates an immediate review of the board’s composition to ensure continued compliance with the minimum standards to independent directors stipulated by SEBI regulations. Shareholders might expect a subsequent announcement regarding the nomination or appointment of a new Independent Director to fill this vacancy.

The company expressed profound grief over the loss, describing it as a significant event to the organization. No further operational or financial details were disclosed in this specific regulatory filing, which focused solely on the personnel change.